Browse > Article
http://dx.doi.org/10.4062/biomolther.2012.20.5.457

Kalopanaxsaponin B Ameliorates TNBS-Induced Colitis in Mice  

Jeong, Jun-Ju (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University)
Jang, Se-Eun (Department of Food and Nutrition, Kyung Hee University)
Joh, Eun-Ha (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University)
Han, Myung-Joo (Department of Food and Nutrition, Kyung Hee University)
Kim, Dong-Hyun (Department of Life and Nanopharmaceutical Sciences and Department of Pharmaceutical Science, Kyung Hee University)
Publication Information
Biomolecules & Therapeutics / v.20, no.5, 2012 , pp. 457-462 More about this Journal
Abstract
The stem-bark of Kalopanax pictus (KP, family Araliaceae), of which main constituent is kalopanaxsaponin B, has been used for asthma, rhinitis, and arthritis in Chinese traditional medicine. To clarify anticolitic effect of KP, we examined anti-inflammatory effect of KP extract and kalopanaxsaponin B in lipopolysaccharide (LPS)-stimulated peritoneal macrophage and 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitic mice. Of KP extracts, KP BuOH-soluble fraction most potently inhibited LPS-induced IL-$1{\beta}$, IL-6 and TNF-${\alpha}$ expression, as well as NF-${\kappa}B$ activation. However, KP BuOH fraction increased IL-10, an anti-inflammatory cytokine. KP BuOH fraction also inhibited colon shortening and myeloperoxidase activity in TNBS-induced colitic mice. KP BuOH fraction also potently inhibited the expression of the pro-inflammatory cytokines, IL-$1{\beta}$, IL-6, and TNF-${\alpha}$ as well as the activation of NF-${\kappa}B$. Kalopanaxsaponin B, a main constituent of KP, inhibited TNBS-induced colonic inflammation, including colon shortening, and TNBS-increased myeloperoxidase activity pro-inflammatory cytokine expression and NF-${\kappa}B$ activation in mice. Based on these findings, KP, particularly its main constituent, kalopanaxsaponin B, may ameliorate colitis by inhibiting NF-${\kappa}B$ pathway.
Keywords
Kalopanaxsaponin B; Kalopanax pictus; Colitis; NF-${\kappa}B$;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., Strand, D., Czaja, J., Schlaak, J. F., Lehr, H. A., Autschbach, F., Schürmann, G., Nishimoto, N., Yoshizaki, K., Ito, H, Kishimoto, T., Galle, P. R., Rose-John, S. and Neurath, M. F. (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat. Med. 6, 583-588.   DOI   ScienceOn
2 Binder, V. (2004) Epidemiology of IBD during the twentieth century: an integrated view. Best Pract. Res. Clin. Gastroenterol. 18, 463-479.   DOI
3 Blanqué, R., Meakin, C., Millet, S., and Gardner, C. R. (1996) Hypothermia as an indicator of the acute effects of lipopolysaccharides: comparison with serum levels of IL1 ${\beta}$, IL6 and TNF ${\alpha}$. Gen. Pharmacol. 27, 973-977.   DOI   ScienceOn
4 Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.   DOI   ScienceOn
5 Cario, E. and Podolsky, D. K. (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68, 7010-7017.   DOI   ScienceOn
6 Choi, J., Huh, K., Kim, S. H., Lee, K. T., Park, H. J. and Han, Y. N. (2002) Antinociceptive and anti-rheumatoidal effects of Kalopanax pictus extract and its saponin components in experimental animals. J. Ethnopharmacol. 79, 199-204.   DOI   ScienceOn
7 Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J. and Gusovsky, F. (1999) Toll-like receptor-4 mediates lipolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689-10692.   DOI   ScienceOn
8 Huang, Y. T., Hwang, J. J., Lee, P. P., Ke, F. C., Huang, J. H., Huang, C. J., Kandaswami, C., Middleton Jr E. and Lee, M. T. (1999) Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br. J. Pharmacol. 128, 999-1010.   DOI   ScienceOn
9 Ingalls, R. R., Heine, H., Lien, E., Yoshimura, A. and Glenbock, D. (1999) Lipopolysaccahride recognition, CD14, and lipopolysaccharide receptors. Infec. Dis. Clin. North Am. 13, 341-353.   DOI   ScienceOn
10 Joh, E. H. and Kim, D. H. (2011) Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-${\kappa}B$ and MAPK pathways. Br. J. Pharmacol. 162, 1731-1742.   DOI
11 Joh, E. H., Lee, I. A., Jung, I. H. and Kim, D. H. (2011) Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation. Biochem. Pharmacol. 82, 278-286.   DOI
12 Kotanidou, A., Xagorari, A., Bagli, E., Kitsanta, P., Fotsis, T., Papapetropoulos, A. and Roussos, C. (2002) Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice. Am. J. Respir. Crit. Care Med. 165, 818-823.   DOI   ScienceOn
13 Joh, E. H., Lee, I. A. and Kim, D. H. (2012) Kalopanaxsaponins A and B isolated from Kalopanax pictus ameliorate memory deficits in mice. Phytother. Res. 26, 546-551.   DOI   ScienceOn
14 Jung, H. C., Eckmann, I., Yang, S. K., Panja, A., Fierer, J., Morzycka-Wroblewska, E. and Kagnoff, M. F. (1995) A distinct array of proinflammatory cytokine is expressed in human colon epithelia cells in response to bacterial invasion. J. Clin. Invest. 95, 55-65.   DOI   ScienceOn
15 Kim, Y. K., Kim, R. G., Park, S. J., Ha, J. H., Choi, J. W., Park, H. J. and Lee, K. T. (2002) In vitro antiinflammatory activity of kalopanaxsaponin A isolated from Kalopanax pictus in murine macrophage RAW 264.7 cells. Biol. Pharm. Bull. 25, 472-476.   DOI   ScienceOn
16 Lee, I. A., Bae, E. A., Hyun, Y. J. and Kim, D. H. (2010a) Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice. J. Inflamm. 7, 7.   DOI
17 Lee, I. A., Hyun, Y. J. and Kim, D. H. (2010b) Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-${\kappa}B$ activation. Eur. J. Pharmacol. 648, 162-170.   DOI
18 Park, H. J., Kim, D. H., Choi, J. W., Park, J. H. and Han, Y. N. (1998) A potent anti-diabetic agent from Kalopanax pictus. Arch. Pharm. Res. 21, 24-29.   DOI
19 Park, H. J., Kwon, S. H., Lee, J. H., Lee, K. H., Miyamoto, K. and Lee, K. T. (2001) Kalopanaxsaponin A is a basic saponin structure for the anti-tumor activity of hederagenin monodesmosides. Planta. Med. 67, 118-121.   DOI   ScienceOn
20 Radema, S. A., van Deventer, S. J. and Cerami, A. (1991) Interleukin 1 ${\beta}$ is expressed predominantly by enterocytes in experimental colitis. Gastroenterology 100, 1180-1186.   DOI
21 Rafii, F., Ruseler-Van Embden, J. G. and van Lieshout, L. M. (1999) Changes in bacterial enzymes and PCR profiles of fecal bacteria from a patient with ulcerative colitis before and after antimicrobial treatments. Dig. Dis. Sci. 44, 637-642.   DOI
22 Shanahan, F. (2002) Crohn's disease. Lancet 359, 62-69.   DOI   ScienceOn